ESMO Breast 2024 | Validating risk prediction models across European screening populations

Mikael Eriksson, PhD, Karolinska Institutet, Solna, Sweden, discusses the validation of risk prediction models in various European settings. Initially trained on Swedish data, these models were tested in Italy, Spain, and Germany, showing similar performance, indicating promising generalizability. Efforts are ongoing to validate these models in the US. This interview took place at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.